Profusa Inc (PFSA)
Profusa Inc is a healthcare equipment and supplies company listed on NASDAQ under the ticker PFSA. The company develops bioengineered sensors designed to detect conditions in the body and transmit clinical-grade data for personal and medical use in the United States. Its current product line includes the Lumee Oxygen Platform, which is intended to monitor compromised tissue in applications such as peripheral artery disease, chronic wounds, and reconstructive surgery. Profusa is also researching the Lumee Glucose Platform, a system designed to measure glucose levels in interstitial fluid. The company is headquartered in Berkeley, California.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-PFSA
|
$1.11
|
-41.7% Downside
|
Overvalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 13, 2026
|
1.157 M
|
14.542 M
|
92.1%
|
85.6%
|
-364.7
|
47.5%
|
